We narrowed to 4,274 results for: sars
-
Plasmid#180067PurposeSars-CoV-2 protein mutationDepositorAvailable sinceJan. 13, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
pDON223 Spike T1027I
Plasmid#180058PurposeSars-CoV-2 protein mutationDepositorInsertSARS-CoV-2 Spike T1027I (S SARS-CoV-2)
TagsMAC-tagExpressionMammalianMutationSpike T1027IAvailable sinceJan. 13, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDON223 Spike D1118H
Plasmid#180068PurposeSars-CoV-2 protein mutationDepositorInsertSARS-CoV-2 Spike D1118H (S SARS-CoV-2)
TagsMAC-tagExpressionMammalianMutationSpike D1118HAvailable sinceJan. 13, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDON223 Spike K417N
Plasmid#180060PurposeSars-CoV-2 protein mutationDepositorAvailable sinceJan. 13, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits -
pDON223 Spike A701V
Plasmid#180062PurposeSars-CoV-2 protein mutationDepositorAvailable sinceJan. 13, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits -
pcDNA-FRT-TO-Nprot_GC3opt
Plasmid#157730Purposemammalian expression of untagged SARS-CoV-2 N protein under control of a tetracycline-inducible promoterDepositorInsertNprot_GC3opt (N SARS-CoV-2)
ExpressionMammalianMutationcodon optimized; gene expression was optimized by…Available sinceAug. 6, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pLEX307-puro-SARS-CoV-2-nsp4-nsp5-L50F-E166A-nsp6
Plasmid#254474PurposeConstitutive expression of SARS-CoV-2 nsp5 with L50F and E166A mutations fused to nsp4 and an N-terminal fragment of nsp6.DepositorInsertSARS-CoV-2 3CL protease with L50F and E166A fused to nsp4 and nsp6
UseLentiviralExpressionMammalianMutationL50F and E166AAvailable sinceAug. 17, 2026AvailabilityAcademic Institutions and Nonprofits only -
pGBW-m4133720
Plasmid#152913PurposeMammalian expression plasmid for SARS-CoV-2 M (membrane)DepositorInsertSARS-CoV-2 M (membrane) (M Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;6xHis-003ExpressionMammalianMutationwtPromoterCMVAvailable sinceJuly 30, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4133594
Plasmid#152881PurposeMammalian expression plasmid for SARS-CoV-2 M (membrane)DepositorInsertSARS-CoV-2 M (membrane) (M Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;V5ExpressionMammalianMutationwtPromoterCMVAvailable sinceJuly 30, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4133645
Plasmid#152869PurposeMammalian expression plasmid for SARS-CoV-2 M (membrane)DepositorInsertSARS-CoV-2 M (membrane) (M Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;3xFlagExpressionMammalianMutationwtPromoterCMVAvailable sinceJuly 30, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4134237
Plasmid#152441PurposeMammalian expression plasmid for SARS-CoV-2 N (nucleocapsid)DepositorInsertSARS-CoV-2 N (nucleocapsid) (N Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;HAExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 17, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4134336
Plasmid#152014PurposeMammalian expression plasmid for SARS-CoV-2 N (nucleocapsid)DepositorInsertSARS-CoV-2 N (nucleocapsid) (N Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;HAExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 17, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4046620
Plasmid#153894PurposeYeast expression plasmid for SARS-CoV-2 M (membrane)DepositorInsertSARS-CoV-2 M (membrane) (M Severe acute respiratory syndrome coronavirus 2)
ExpressionYeastMutationwtPromoterpGAL1Available sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4252945
Plasmid#153788PurposeMammalian expression plasmid for SARS-CoV-2 E (envelope)DepositorInsertSARS-CoV-2 E (envelope) (E Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;6xHis-003ExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4252875
Plasmid#153789PurposeMammalian expression plasmid for SARS-CoV-2 E (envelope)DepositorInsertSARS-CoV-2 E (envelope) (E Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;3xFlagExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4252903
Plasmid#153778PurposeMammalian expression plasmid for SARS-CoV-2 E (envelope)DepositorInsertSARS-CoV-2 E (envelope) (E Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;V5ExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4133220
Plasmid#153728PurposeMammalian expression plasmid for SARS-CoV-2 E (envelope)DepositorInsertSARS-CoV-2 E (envelope) (E Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;V5ExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4252828
Plasmid#153693PurposeMammalian expression plasmid for SARS-CoV-2 E (envelope)DepositorInsertSARS-CoV-2 E (envelope) (E Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;V5ExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGBW-m4133425
Plasmid#153661PurposeMammalian expression plasmid for SARS-CoV-2 E (envelope)DepositorInsertSARS-CoV-2 E (envelope) (E Severe acute respiratory syndrome coronavirus 2)
TagsCleavable TEV;HAExpressionMammalianMutationwtPromoterCMVAvailable sinceJune 12, 2020AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pGBW-m4046173
Plasmid#149126PurposeYeast Expression plasmid for SARS-CoV-2 N (nucleocapsid)DepositorInsertSARS-CoV-2 N (nucleocapsid) (N Budding Yeast, Severe acute respiratory syndrome coronavirus 2)
TagsCleavable thrombin;3xFLAGExpressionYeastMutationSaccharomyces cerevisiae recode 1PromoterpTEF1Available sinceMay 14, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits